Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183095
Max Phase: Preclinical
Molecular Formula: C27H28ClN5O5S2
Molecular Weight: 602.14
Associated Items:
ID: ALA5183095
Max Phase: Preclinical
Molecular Formula: C27H28ClN5O5S2
Molecular Weight: 602.14
Associated Items:
Canonical SMILES: CCS(=O)(=O)NC(=O)c1nc(N(CC2CC2)[C@H](C)c2ccc(-c3cc(Cl)ccc3-c3nc(=O)o[nH]3)cc2)sc1C
Standard InChI: InChI=1S/C27H28ClN5O5S2/c1-4-40(36,37)32-25(34)23-16(3)39-26(29-23)33(14-17-5-6-17)15(2)18-7-9-19(10-8-18)22-13-20(28)11-12-21(22)24-30-27(35)38-31-24/h7-13,15,17H,4-6,14H2,1-3H3,(H,32,34)(H,30,31,35)/t15-/m1/s1
Standard InChI Key: MPSZZEIWORIIPB-OAHLLOKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 602.14 | Molecular Weight (Monoisotopic): 601.1220 | AlogP: 5.17 | #Rotatable Bonds: 10 |
Polar Surface Area: 138.26 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.68 | CX Basic pKa: 0.50 | CX LogP: 5.83 | CX LogD: 3.93 |
Aromatic Rings: 4 | Heavy Atoms: 40 | QED Weighted: 0.25 | Np Likeness Score: -0.97 |
1. Imaizumi T, Otsubo S, Maemoto M, Kobayashi A, Komai M, Takada H, Sakaida Y, Otsubo N.. (2022) Discovery and mechanistic study of thiazole-4-acylsulfonamide derivatives as potent and orally active ChemR23 inhibitors with a long-acting effect in cynomolgus monkeys., 56 [PMID:35063894] [10.1016/j.bmc.2021.116587] |
Source(1):